DOCSLIB.ORG

Curriculum Vitae

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Curriculum Vitae CURRICULUM VITAE NAME: Run Wang, MD, FACS PRESENT TITLE: Professor Cecil M. Crigler, MD, Chair in Urology ADDRESS: University of Texas Medical School at Houston 6431 Fannin Street, Suite 6.018 Houston, Texas 77030 BIRTH DATE: August 2, 1960 CITIZENSHIP: U.S.A. UNDERGRADUATE EDUCATION: Southeast University Medical College (Formerly Nanjing Railway Medical College), Nanjing, China 09/1978 – 08/1983 MD GRADUATE EDUCATION: Southeast University Medical College (Formerly Nanjing Railway Medical College), Nanjing, China 09/1983 – 07/1986 MS POSTGRADUATE TRAINING: Rotating Internship (Medicine, Surgery, Pediatrics, OB/Gyn), Nanjing First People's Hospital, Nanjing, China 07/1982 – 07/1983 Residency: Urology, Southeast University Medical College (Formerly Nanjing Railway Medical College), Nanjing, China 08/1983 – 07/1986 Visiting Fellowship: Department of Urology, Nijmegen University, Nijmegen, The Netherlands 06/1990 – 09/1990 Fellowship: Urological Andrology (Impotence and Infertility Research), Department of Urology, Tulane University, New Orleans, Louisiana 09/1990 – 09/1993 Internship: General Surgery, Medical College of Georgia, Augusta, Georgia 07/1997 – 06/1998 1 Residency: Urology, Medical College of Georgia, Augusta, Georgia 07/1998 – 06/2001 Chief Resident: Urology, Medical College of Georgia, Augusta, Georgia 07/2001 – 06/2002 ACADEMIC APPOINTMENTS: Assistant Professor, Department of Urology, Southeast University Medical College (Formerly Nanjing Railway Medical College), Nanjing, China 07/1986 - 06/1990 Academic Secretary, Chinese Railway Urological Association, Nanjing, China 07/1988 - 06/1990 Research Instructor, Department of Urology, Tulane University, New Orleans, Louisiana 07/1992 – 08/1993 Senior Research Instructor, Department of Urology, Tulane University, New Orleans, Louisiana 07/1995 – 08/1996 Research Assistant Professor, Department of Urology, Tulane University, New Orleans, Louisiana 07/1996 – 08/1997 Assistant Professor, Division of Urology, Department of Surgery, University of Texas Medical School at Houston, Houston, Texas 09/2002 – 08/2006 Assistant Professor, Department of Urology, University of Texas MD Anderson Cancer Center, Houston, Texas 12/2002 – 08/2006 Concurrent Professor, Department of Urology, Medical School of Nanjing University, Nanjing, China 08/2004 – present Concurrent Professor, Medical School of Beijing University Andrology Center, Beijing, China 01/2006 – present Concurrent Professor, Department of Urology, Sichuan University, Chengdu, China 03/2006 – present Honorary Professor, Peking University Urological Training College, Beijing, China 05/2006 – present Associate Professor, Division of Urology, Department of Surgery, University of Texas Medical School at Houston, Houston, Texas 09/2006 – 08/2011 2 Associate Professor, Department of Urology, University of Texas MD Anderson Cancer Center, Houston, Texas 09/2006 – 08/2011 Cecil M. Crigler, M.D. Chair in Urology, Division of Urology, Department of Surgery, University of Texas Medical School at Houston, Houston, Texas 01/2008 – present Professor, Division of Urology, Department of Surgery, University of Texas Medical School at Houston, Houston, Texas 09/2011 - present Professor, Department of Urology, University of Texas MD Anderson Cancer Center, Houston, Texas 09/2011 – present Guest Professor, Southeast University, Nanjing, China, October, 2011 – Present. Honorary Chief of Department of Urology, Zhongda Hospital, Southeast University, Nanjing China, October, 2011 – Present. HOSPITAL APPOINTMENTS: 1986 – 1990 Zhong Da Hospital, Nanjing, China 2002 - present Memorial Hermann Hospital, Houston, Texas 2002 - present Director, Sexual Medicine, Department of Urology, University of Texas MD Anderson Cancer Center, Houston, Texas 09/2002-08/2006 Chief of Urology, Lyndon Baines Johnson General Hospital, Houston, Texas, 09/2002 – present Lyndon B. Johnson General Hospital, Houston, Texas 2003 – 2010 Houston Hospital for Specialized Surgery, Houston, Texas 2004 – 2006 Texas Children’s Hospital, Houston, Texas LICENSURE: Composite State Board of Medical Examiners, State of Georgia License: 049676, 2001 Texas State Board of Medical Examiners License: 5176, 2002 Louisiana State Board of Medical Examiners License: MD202686, 2008 CERTIFICATION: 1994 Laserscope (KTP/532 and Nd:YAG Lasers) Training Certificate 1996 ECFMG Certificate, 0-542-765-3 2000 MDLR Holmium Laser Training Certificate 2002 Drug Enforcement Administration Certificate, BW8002785 3 2002 Texas Controlled Substances Registration Certificate, 90125860 2003 Intuitive Surgical da Vinci Surgical System Training Certificate 2004 Diploma of the American Board of Urology 2005 Fellow of American College of Surgeons PROFESSIONAL ORGANIZATIONS: LOCAL: Chinese American Doctors Association of Houston - Life Time Member REGIONAL: American Urological Association, South Central Section - Active Member NATIONAL: American Urological Association - Active Member American Society of Andrology - Active Member Society of University Urologists - Active Member Society of Genitourinary Reconstructive Surgeons - Active Member INTERNATIONAL: Endourological Society - Active Member International Society for Sexual Medicine - Active Member Sexual Medicine Society of North America - Active Member Chinese Association of Clinical Urologists - International Member The 3rd WHO International Consultation on Sexual Medicine - Member ELECTED POSITIONS HELD IN PROFESSIONAL ORGANIZATIONS: 2007 – 2009 Chairman: Scientific Program Committee, World Chinese Urological Society 2007 – 2009 Board of Directors (Member at Large): Sexual Medicine Society of North America 2008 – 2010 Co-Chairman: Membership Committee, American Society of Andrology 2009 – present Secretary: Global Chinese Urological Society 2010 – present Treasurer: Sexual Medicine Society of North America HONORS AND AWARDS: 1980, 1982 Outstanding medical student, Southeast University School of Medicine (Former Nanjing Railway Medical College). 1983 Honors in internships (medicine, surgery, pediatrics, ob/gyn), Nanjing First People's Hospital. 1986 Prize presentation, postgraduate research in Jiangsu province ("Varicocele and Male Infertility"). 1988 First prize award: Varicocele in the Rat: A New Experimental Model. The First Congress of Chinese Railway Urological Association, Nanjing, China. 1992 Excellent research award: DNA analysis in the early evaluation of adult polycystic kidney disease (APKD). Jiangsu Science and Technology Committee, Nanjing, China. 4 1993 Prize poster: Role of Platelet Activating Factor (PAF) and Pentoxifylline (PTX) as Human Sperm Cryoprotectants. The V International Congress of Andrology, Tokyo, Japan. 1997 Prize presentation: Stimulation of Sperm with peptides. The XXVI Congress of Brazil Urology, Blumenau, Brazil. 1999, 2001 Pfizer scholars in Urology award 2002 Alpha Omega Alpha honor medical society 2002 SUA Foundation Scholar 2004 President’s award for outstanding andrology research. The 5th Congress of the Chinese Society of Andrology, Nanjing, China. 2006 The best educational lecture in urology, International Urology Forum and IX Urology Conference of Sichuan Province, Chengdu, China. 2009 – present Honorary Consultant: Macau Urological Association. May 29, 2010 Best poster: Gene therapy with SuperEnzyme for ED after cavernosal nerve crush injury in rat. The 5th World Chinese Urological Society Meeting, San Francisco, CA. November 10 – 13, 2011 The “Best Of” Top 10 Basic Science Papers: Penile rehabilitation with vacuum erectile device in animal model is related to anti-hypoxic mechanism: blood gas evidence. The 17th Annual Fall Scientific Meeting of Sexual Medicine Society of North America, Las Vegas. EDITORIAL POSITIONS: 2000 – present National Journal of Andrology, Editorial Director 2004 – present Journal of Sexual Medicine, Reviewer 2004 – present Cellular and Molecular Life Sciences, Reviewer 2005 – present Chinese Journal of Urology, Editorial Board Member 2005 – present QJM An International Journal of Medicine, Reviewer 2005 – present Journal of Urology, Reviewer 2007 – present Asian Journal of Andrology, Editorial Board Member 2007 – present Recent Patents on Cardiovascular Drug Discovery, Reviewer 2007 – present Current Urology, Editorial Board Member January 2008 Asian Journal of Andrology, Guest Editor 2008 – present Journal of Andrology, Editorial Board Member 2008 – present Expert Opinion on Investigational Drugs, Reviewer 2009 – present International Journal of Andrology, Reviewer 2009 – present Journal of Modern Urology, Associate Editor 2010 – present Journal of Urology for Clinicians, Editorial Board Member 2011 – present National Journal of Andrology, Associate Editor 2011 – present American Journal of Integrative Medicine, Associate Editor for Surgery/Urology 5 2011 – present Transitional Andrology and Urology, Editorial Board Member SERVICE ON INTERNATIONAL AND NATIONAL GRANT REVIEW PANELS, STUDY SECTIONS, COMMITTEES: 2005 - present Chinese Association of Clinical Urologists, Educational Committee Member 2007- 2009 International Society for Sexual Medicine, Education Committee Member 2007- 2009 Sexual Medicine Society of North America, Board of Directors 2007- present Sexual Medicine Society of North America – Membership Committee 2007 - present Dannemiller Memorial Educational Foundation, Clinical Content Review Committee 2008 - present American Society of Andrology, Co-Chairman, Membership Committee 2009 - present American Urological Association, Program Abstract Review Committee SERVICE ON THE UNIVERSITY
Load more

Recommended publications
  • Guidelines on Paediatric Urology S
    Guidelines on Paediatric Urology S. Tekgül (Chair), H.S. Dogan, E. Erdem (Guidelines Associate), P. Hoebeke, R. Ko˘cvara, J.M. Nijman (Vice-chair), C. Radmayr, M.S. Silay (Guidelines Associate), R. Stein, S. Undre (Guidelines Associate) European Society for Paediatric Urology © European Association of Urology 2015 TABLE OF CONTENTS PAGE 1. INTRODUCTION 7 1.1 Aim 7 1.2 Publication history 7 2. METHODS 8 3. THE GUIDELINE 8 3A PHIMOSIS 8 3A.1 Epidemiology, aetiology and pathophysiology 8 3A.2 Classification systems 8 3A.3 Diagnostic evaluation 8 3A.4 Disease management 8 3A.5 Follow-up 9 3A.6 Conclusions and recommendations on phimosis 9 3B CRYPTORCHIDISM 9 3B.1 Epidemiology, aetiology and pathophysiology 9 3B.2 Classification systems 9 3B.3 Diagnostic evaluation 10 3B.4 Disease management 10 3B.4.1 Medical therapy 10 3B.4.2 Surgery 10 3B.5 Follow-up 11 3B.6 Recommendations for cryptorchidism 11 3C HYDROCELE 12 3C.1 Epidemiology, aetiology and pathophysiology 12 3C.2 Diagnostic evaluation 12 3C.3 Disease management 12 3C.4 Recommendations for the management of hydrocele 12 3D ACUTE SCROTUM IN CHILDREN 13 3D.1 Epidemiology, aetiology and pathophysiology 13 3D.2 Diagnostic evaluation 13 3D.3 Disease management 14 3D.3.1 Epididymitis 14 3D.3.2 Testicular torsion 14 3D.3.3 Surgical treatment 14 3D.4 Follow-up 14 3D.4.1 Fertility 14 3D.4.2 Subfertility 14 3D.4.3 Androgen levels 15 3D.4.4 Testicular cancer 15 3D.5 Recommendations for the treatment of acute scrotum in children 15 3E HYPOSPADIAS 15 3E.1 Epidemiology, aetiology and pathophysiology
    [Show full text]
  • Vasectomy Reversal (VR)
    Vasectomy Reversal (VR) ! Need to know Please read this before your Vasectomy Reversal Preparing for the VR • Do not eat or drink after midnight if your operation is in the morning and not after 7.00am if it is in the afternoon. • Please shave the hair at the front and sides of the scrotum from the base of the penis down. You do not need to shave the pubic hair • Take supportive underpants (not your best) or a jockstrap into the hospital with you and to theatre to wear after the operation. • Arrange a week off work. • Avoid intercourse for two weeks after the operation and heavy lifting for four weeks. REF 0000.0 – 12/15 What to expect during the VR • An infection of the scrotum rarely occurs but if it does, • An incision is placed on each side of the scrotum that will present a few days after the surgery and is apparent are a little larger than those used for the vasectomy. because the pain becomes worse rather than better and the scrotum becomes red. • The vas is a very small muscular tube with a 2mm outer diameter and an inner diameter through which If you experience any of the above complications or sperm flow (the lumen), of less than 1/2mm. Since the have any other problem occur after your VR, please structure is so small, the stitches must be placed very call the Clinic or your Surgeon if outside clinic exactly so that there is minimal scarring. Too much hours. scarring can cause the lumen of the vas to close and the procedure to fail.
    [Show full text]
  • Semen Parameters of Cancer Patients at Diagnosis
    FERTILITY AND STERILITY௡ VOL. 82, NO. 2, AUGUST 2004 Copyright ©2004 American Society for Reproductive Medicine Published by Elsevier Inc. Printed on acid-free paper in U.S.A. Normal semen parameters in cancer patients presenting for cryopreservation before gonadotoxic therapy Similar sperm qualities in men with and without cancer were found. Patient and physician awareness and early referral for sperm banking are essential in preserving fertility potential in men with malignancies. (Fertil Steril௡ 2004;82:505–6. ©2004 by American Society for Reproductive Medicine.) Prior investigators have reported that more than half of the men of reproductive age with malignancies, such as testicular cancer and lymphoma, have impaired semen quality (1, 2). Chemotherapy or radiotherapy can further damage spermatogenesis, with lasting effects of up to 5 years (3). With increased awareness of the need for sperm banking, men have been presenting for cryopreservation soon after diagnosis. However, physicians might fail to offer cryopreservation to men with cancer, assuming that the semen quality is too impaired and that the fertility potential will further be decreased by the process of cryopreservation (4). With sophisticated assisted reproductive techniques, pregnancies and deliveries have been reported with cryopre- served spermatozoa from cancer patients, without increased risk of congenital anomalies (5, 6). In addition, with excellent cure rates for testicular cancer and increased survival in many urologic and nonurologic malignancies, most cancer survivors want to have children. We present a comparative analysis of sperm quality and postthaw survival in men with and without malignancies. The statistical database of all men seeking sperm cryopreservation at a single licensed and accredited sperm bank was reviewed from 1997 to 2001.
    [Show full text]
  • 2002 Asa Program.Pdf
    schedule at a lance Wednesday, April 24, 2002 • Genetics and Biology of Adult Male Germ Cell 8:00 am Andrology Laboratory Workshop Tumors The Andrology Laboratory of the Future: Raju S.K. Chaganti, Memoria l Sloan-Kettering Impact of the Genomic and Proteomic • Modeling Human Disease Through Transgenesis Revolutions (concludes at 5:00 pm) Sarah Comerford, UTSWMS & HHI • How to Find Cellular Proteins that Sense the 5:30 pm Welcome and Opening Remarks Environment Da vid Garbers, HHM/ 5:45 pm Distinguished Andrologist Award 6:00 pm Serano Lecture 12:00 pm Laboratory Science Lunch • Of Genes and Genomes 1:30 pm Symposium Ill: Do Gene Defects Impact Da vid Botstein, Stanford University Male Reproduction: If So, How? •The Battle of the Sexes: Sry and the Control of Testis 7:15 pm Welcome Reception Organogenesis Blanche Capel, Duke Univ. Med. Ctr. Thursday, April 25, 2002 • Natural Potent Androgens: Lessons from Human Genetic Models 8:00 am Solvay/Unimed Lecture J. /mperato-McGinley, Cornell University •Androgen Therapy in the Older Man-Where • Genetic Defects in Male Reproduction Are We Now and Where Are We Going? Stephanie Seminara, Harvard University Lisa Te nover, Emory University 3:00 pm Refreshment Break and Exhibits 8:55 am Distinguished Service Award 3:15 pm Plenary Lecture 9:05 am Biopore Lecture • The Ins & Outs of PSMA, the Evolving and • Global Analysis of Germline Gene Expression Intriguing Tale of its Prostate Biology & Tumor Sam Wa rd, University of Arizona Targeting WO. Heston, Cleveland Clinic 10:00 am Coffee Break and Exhibits 4:05 pm Schering Lecture 10:30 am Concurrent Oral Sessions I, II, Ill • Bioethics and Stem Cell Research • Basic and Clinical Aspects of Male Sexual Laurie Zoloff, San Fra ncisco State Univ.
    [Show full text]
  • Microsurgical Vasectomy Reversal: Results and Predictors of Success
    9REVUE Andrologie 2005, 15, N~ 167-171 Microsurgical vasectomy reversal : results and predictors of success Gert R. DOHLE, Marij SMIT Andrology unit, Department of Urology, Erasmus University Medical Centre, Rotterdam, The Netherlands ABSTRACT successfully. The results of vasectomy reversal procedu- res can be improved substantially if the surgeon is able to perform a vaso-epididymostomy in cases of a secondary Microsurgical vasectomy reversal is a challenge for the epididymal obstruction, occurring in about 25% of men physician but successful treatment depends on the expe- with an interval of more than 10 years. rience and skills of the surgeon. Fertility can often be res- tored, thus avoiding the need for artificial reproductive techniques. Also, the surgical procedures can be combi- Key words : male infertility, microsurgery, vasectomy rever- ned with sperm aspiration and cryopreservation, to be sal, vasoepididymostemy used for Intracytoplasmic sperm injection (ICSI) in cases of surgical failure. We describe the results of 217 vasova- sostomy procedures, with special emphasis on recent technical refinements and prognostic indicators. I. INTRODUCTION Between 1998 and 2002 we performed 217 vasovasosto- my-procedures in an outpatient clinic setting. Microsurgery in urology is mainly applied in obstructive Refertilisation was successful in 76.5%, spontaneous pre- male infertility and varicocele repair. Other indications are gnancy occurred in 42% of the couples after a follow-up vascular erectile dysfunction and penile or testicular vas- of at least 1 year. The main prognostic factors determi- cular trauma. Obstructions of the male genital tract repre- ning the outcome of the surgery was the interval between sent 5-10% of the causes of male infertility and in 70-80% vasectomy and refertilisation and the age of the female of these men surgical repair can be performed [11].
    [Show full text]
  • Semen Parameters in Men with Spinal Cord Injury: Changes and Aetiology
    Infertility and spinal cord injury DOI: 10.1111/J.1745-7262.2007.00277.X www.asiaandro.com .Original Article . Semen parameters in men with spinal cord injury: changes and aetiology Mohamed N. Momen1, Ibrahim Fahmy1, Medhat Amer1,2, Mohamad Arafa1, Wael Zohdy1, Taha A. Naser1 1Andrology Department, Cairo University, Cairo, Egypt 2Adam International Clinic, Giza 12411, Egypt Abstract Aim: To assess the changes in semen parameters in men with spinal cord injury (SCI) and the possible causes of these changes. Methods: The study included 45 subjects with SCI. Semen retrieval was done by masturbation (2), vigorous prostatic massage (n = 13), penile vibratory stimulation (n = 13) or electroejaculation (n = 17). Results: The semen of men with SCI showed normal volume (2.3 ± 1.9 mL) and sperm count (85.0 × 106 ± 83.8 × 106/mL) with decreased motility (11.6% ± 10.1%), vitality (18.5% ± 15.2%) and normal forms (17.5 ± 13.4%), and pus cells has been increased (6.0 × 106 ± 8.2 × 106/mL). Total (13.4 ± 9.9 vs. 7.1 ± 6.8) and progressive (4.4 ± 3.9 vs. 2.2 ± 2.1) motility were significantly higher in subjects with lower scrotal temperatures. There was no statistical significant difference between electroejaculation and penile vibratory stimulation groups as regards any of the semen parameters. Subjects’ age, infrequent ejaculation, injury duration and hormonal profile showed no significant effect on semen parameters. Conclusion: The defining characteristics of the seminogram in men with SCI are normal volume and count with decreased sperm motility, vitality and normal forms, and the increased number of pus cells.
    [Show full text]
  • Male Fertility Questionnaire
    140 Charlois Blvd Winston-Salem, NC 27103 P 336.716.4131 / f 336.716.9042 Director Ryan Terlecki, MD, FACS www.wakeforestmenshealth.com Male Fertility Questionnaire Name: Address: Phone (home): Phone (cell): Email: Date of Birth: Relationship Status: o Single o Married o Divorced o Separated o Widowed Partner Name (if applicable): Partner contact (phone/email): Only complete the following questions if you HAVE NOT HAD A VASECTOMY: For how many months have you been trying to achieve pregnancy with your current partner? Age of current partner: Have you ever been involved with a prior pregnancy with your current partner? (Yes/No) : If so, please provide date/outcome of each: Have you ever been involved with a prior pregnancy with a different partner? (Yes/No) : If so, please provide date/outcome of each: Has your partner ever achieved pregnancy with someone else? (Yes/No) : If so, please provide date/outcome of each: Have you used any of the following forms of contraception? (Yes/No): o condoms o diaphragm o vaginal foam o IUD o oral contraceptives o rhythm method Have you had a prior semen analysis? (Yes/No): If so, was the analysis abnormal? (Yes/No): If so, check all that apply: o no sperm o low sperm count o poor motility o poor morphology How many times per week do you achieve ejaculation within your partner’s vagina? 140 Charlois Blvd Winston-Salem, NC 27103 P 336.716.4131 / f 336.716.9042 Director Ryan Terlecki, MD, FACS www.wakeforestmenshealth.com Do you use any products for lubrication during sexual activity? Has your partner ever
    [Show full text]
  • Post-Coital DNA Recovery Study
    The author(s) shown below used Federal funds provided by the U.S. Department of Justice and prepared the following final report: Document Title: Post-Coital DNA Recovery Study Author(s): Patricia Speck, Jack Ballantyne Document No.: 248682 Date Received: March 2015 Award Number: 2009-DN-BX-0023 This report has not been published by the U.S. Department of Justice. To provide better customer service, NCJRS has made this federally funded grant report available electronically. Opinions or points of view expressed are those of the author(s) and do not necessarily reflect the official position or policies of the U.S. Department of Justice. August 31, 2014 Post-Coital DNA Recovery Study Final Report NIJ Grant No. 2009-DN-BX-0023 Performance Period: January 2010 through July 2014 Prepared for National Institute of Justice 810 Seventh Street, NW Washington, DC 20001 Prepared by Principle Investigator Patricia Speck, DNSc, APN, FNP-BC, DF-IAFN, FAAFS, FAAN The University of Tennessee Health Science Center College of Nursing Department of Advanced Practice and Doctoral Studies (Ret.) University of Alabama Birmingham School of Nursing Department of Family, Community and Health Systems NB-302 | 1720 Second Avenue South | Birmingham, AL 35294-1210 P: 205.934-6790 C: 901.488-7723 Email: [email protected] Co-Principle Investigator Jack Ballantyne, PhD University of Central Florida National Center for Forensic Science ii This document is a research report submitted to the U.S. Department of Justice. This report has not been published by the Department. Opinions or points of view expressed are those of the author(s) and do not necessarily reflect the official position or policies of the U.S.
    [Show full text]
  • Collection Procedure for Semen Analysis
    1255 West Washington Street Tempe, Arizona 85281 602.685.5000 | 800.766.6721 SonoraQuest.com Collection Procedure for Semen Analysis (Please follow all instructions to assure proper specimen collection) For test codes: 703640 - Semen Analysis Complete 901289 - Semen Analysis Post-Vasectomy w/Reflex to Count/Motility, follow the instructions below Call 1-855-367-2778 to schedule an appointment at one of the facilities below. These are time sensitive tests and an appointment is required. Tempe: 1275 W. Washington Street, Suite 109, Tempe, AZ 85281 Tucson: 630 N Alvernon Way, Suite 200, Tucson, AZ 85771 Collection Procedure: 1. The semen specimen should be collected after 2-7 days of sexual abstinence unless otherwise instructed by your physician. 2. The specimen must be collected at one of the Patient Service Centers listed above. 3. Collect the specimen by masturbation into a sterile container (containers are provided by the laboratory). Since the volume of semen produced may be significant to diagnosis, it is important to submit the entire specimen. Be sure the container lid is closed tightly. 4. Label the container with your name, date of collection and exact time of collection. In addition the information below is needed to properly evaluate the results of this test. If you have any question about how to answer the questions, please ask your doctor or a Sonora Quest Laboratories employee. Please mark down the number of days of abstinence (days since last ejaculation) Method of collection was masturbation (REQUIRED) For test codes: 3645 - Semen Analysis, Post Vasectomy 900865 - Semen Analysis, Post-Vasectomy w/Reflex to Count, follows the instructions below Collection Procedure: 1.
    [Show full text]
  • 2019 Compilation of Inpatient Only Procedure Lists by Specialty
    2019 Compilation of Inpatient Only Procedure Lists by Specialty (for CPT searching) 2019 Bariatric Surgery: Is the Surgery Medicare Inpatient Only or not? Disclaimer: This is not the CMS Inpatient Only Procedure List (Annual OPPS Addendum E). No guarantee can be made of the accuracy of this information which was compiled from public sources. CPT Codes are property of the AMA and are made available to the public only for non-commercial usage. Gastric Bypass or Partial Gastrectomy Procedures Inpatient Only Procedure Not an Inpatient Only Procedure 43644 Laparoscopy, surgical, gastric restrictive 43659 Unlisted laparoscopy procedure, stomach procedure; with gastric bypass and Roux-en-Y gastroenterostomy (roux limb 150 cm or less) 43645 Laparoscopy, surgical, gastric restrictive procedure; with gastric bypass and small intestine reconstruction to limit absorption 43775 Laparoscopy, surgical, gastric restrictive procedure; longitudinal gastrectomy (ie, sleeve gastrectomy) 43843 Gastric restrictive procedure, without gastric bypass, for morbid obesity; other than vertical- banded gastroplasty 43845 Gastric restrictive procedure with partial gastrectomy, pylorus-preserving duodenoileostomy and ileoileostomy (50 to 100 cm common channel) to limit absorption (biliopancreatic diversion with duodenal switch) 43846 Gastric restrictive procedure, with gastric bypass for morbid obesity; with short limb (150 cm or less) Roux-en-Y gastroenterostomy 43847 Gastric restrictive procedure, with gastric bypass for morbid obesity; with small intestine reconstruction
    [Show full text]
  • Examination and Processing of Human Semen
    WHO laboratory manual for the Examination and processing of human semen FIFTH EDITION WHO laboratory manual for the Examination and processing of human semen FIFTH EDITION WHO Library Cataloguing-in-Publication Data WHO laboratory manual for the examination and processing of human semen - 5th ed. Previous editions had different title : WHO laboratory manual for the examination of human semen and sperm-cervical mucus interaction. 1.Semen - chemistry. 2.Semen - laboratory manuals. 3.Spermatozoa - laboratory manuals. 4.Sperm count. 5.Sperm-ovum interactions - laboratory manuals. 6.Laboratory techniques and procedures - standards. 7.Quality control. I.World Health Organization. ISBN 978 92 4 154778 9 (NLM classifi cation: QY 190) © World Health Organization 2010 All rights reserved. Publications of the World Health Organization can be obtained from WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel.: +41 22 791 3264; fax: +41 22 791 4857; e-mail: [email protected]). Requests for permission to reproduce or translate WHO publications— whether for sale or for noncommercial distribution—should be addressed to WHO Press, at the above address (fax: +41 22 791 4806; e-mail: [email protected]). The designations employed and the presentation of the material in this publication do not imply the expres- sion of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. The mention of specifi c companies or of certain manufacturers’ products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned.
    [Show full text]
  • EAU Pocket Guidelines on Male Infertility 2003
    EAU GUIDELINES POCKET EDITION 1 CONTENTS: INFERTILITY ERECTILE DYSFUNCTION MANAGEMENT of URINARY and MALE GENITAL TRACT INFECTIONS 2 3 EAU POCKET GUIDELINES EDITION 1 Introduction This is one of a series of convenient pocket size books (currently 3) offering a comprised version of several EAU guidelines. These short texts are based on the currently avai- lable extended guidelines texts and can serve as a quick refe- rence guide for medical professionals. The EAU considers it to be of paramount importance to con- tinuously update its guidelines texts and introduce new data and the latest versions can be viewed online at http://www.uroweb.nl. All EAU members will automatically receive a printed version. Board EAU Healthcare Office March 2003 EAU POCKET GUIDELINES EDITION 1 Introduction Introduction 4 GUIDELINES FOR THE INVESTIGATION 2 Diagnosis 5 2.1 Introduction AND TREATMENT OF MALE INFERTILITY The diagnosis of male fertility must focus on a number of prevalent disorders, such as varicocele, testicular and epididy- mal abnormalities, obstructions of the genital tract, and anom- G. Dohle and the members of the guidelines working party alies of prostate and seminal vesicles (Table 1). Simultaneous on Male Infertility. assessment of the female partner is preferable, even if abnor- malities are found in the male. GUIDELINES ON INFERTILITY 1. INTRODUCTION 1.1 Definition Table 1: The main cause of male infertility “Infertility is the inability of a sexually active, non-contracept- Testicular insufficiency ing couple to achieve pregnancy in one year” (WHO, 1995). ¼ Cryptorchidism About 25% of couples do not achieve pregnancy within 1 ¼ Orchitis (viral) year.
    [Show full text]